Sept 30 (Reuters) - Bristol Myers Squibb ( BMY ) won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene. U.S. District Judge Jesse Furman in Manhattan said UMB Bank was never properly appointed trustee for shareholders owning...

01:28 PM EDT, 09/30/2024 (MT Newswires) -- BlackRock ( BLK ) has entered a recapitalization agreement that with SellerX that would make it the brand aggregator's largest shareholder, Bloomberg reported Monday. SellerX confirmed a recapitalization agreement with lenders on its website but did not specify any names. With this agreement, we can move forward with renewed vigour, backed by greater...

(Reuters) - Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene. U.S. District Judge Jesse Furman in Manhattan said UMB Bank was never properly appointed trustee for shareholders owning contingent value rights (CVR) because...

01:56 PM EDT, 09/30/2024 (MT Newswires) -- RPM International ( RPM ) said Monday that a jury rendered a $190 million verdict against a subsidiary in its consumer reportable segment in a lawsuit filed in federal court in Oregon. A former supplier accused the subsidiary of violating certain contractual obligations, misappropriating trade secrets and committing fraud, RPM said in a...